Research and Markets has announced the addition of the "Serine/Threonine Protein Kinase ATR (Ataxia Telangiectasia And Rad3 Related Protein or FRAP Related Protein 1 or ATR or EC 18.104.22.168) - Pipeline Review, H2 2016" report to their offering.
'SerineThreonine Protein Kinase ATR - Pipeline Review, H2 2016'; Serine
Threonine Protein Kinase ATR pipeline Target constitutes close to 7 molecules. Out of which approximately 7 molecules are developed by Companies.
Serine/Threonine Protein Kinase ATR Serine/threonine-protein kinase ATR is an enzyme encoded by the ATR gene. It is required for cell cycle arrest and DNA damage repair in response to DNA damage. It has shown to phosphorylate checkpoint kinase CHK1, checkpoint proteins RAD17, and RAD9, as well as tumor suppressor protein BRCA1.
The report 'SerineThreonine Protein Kinase ATR - Pipeline Review, H2 2016' outlays comprehensive information on the Serine/Threonine Protein Kinase ATR targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.
It also reviews key players involved in Serine/Threonine Protein Kinase ATR targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Currently, The molecules developed by Companies in Phase II, Phase I and Preclinical stages are 1, 2 and 4 respectively.
Key Topics Covered:
For more information about this report visit http://www.researchandmarkets.com/research/8vdh6p/serinethreonine
View source version on businesswire.com: http://www.businesswire.com/news/home/20160920005823/en/Business Wire
Last updated on: 20/09/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.